相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardioprotective Properties of the Platelet P2Y12 Receptor Inhibitor, Cangrelor: Protective in Diabetics and Reliant Upon the Presence of Blood
R. M. Bell et al.
CARDIOVASCULAR DRUGS AND THERAPY (2015)
Triple Therapy Greatly Increases Myocardial Salvage During Ischemia/Reperfusion in the in situ Rat Heart
Xi-Ming Yang et al.
CARDIOVASCULAR DRUGS AND THERAPY (2013)
Platelet P2Y12 Blockers Confer Direct Postconditioning-Like Protection in Reperfused Rabbit Hearts
Xi-Ming Yang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2013)
Interplay Between SAFE and RISK Pathways in Sphingosine-1-Phosphate-Induced Cardioprotection
Sarin J. Somers et al.
CARDIOVASCULAR DRUGS AND THERAPY (2012)
Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets
M Tani et al.
JOURNAL OF LIPID RESEARCH (2005)
Postconditioning's protection is not dependent on circulatin blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation
XM Yang et al.
BASIC RESEARCH IN CARDIOLOGY (2005)
New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway
DJ Hausenloy et al.
CARDIOVASCULAR RESEARCH (2004)
Sphingosine kinase activation mediates ischemic preconditioning in murine heart
ZQ Jin et al.
CIRCULATION (2004)
Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury
DJ Hausenloy et al.
CARDIOVASCULAR RESEARCH (2003)
Identification of a novel role for sphingolipid signaling in TNFα and ischemic preconditioning mediated cardioprotection
S Lecour et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
分享论文
